HSP90B2P and hepatocellular carcinoma: Zhang et al. experimented via mitochondrial pathway in vitro on HepG-2, SMMC-7721 and Huh-7 cell line and in vivo Xenograft mouse model and stated that HSP (25–600 μM) inhibited hepatocellular carcinoma by inducing apoptosis and cell viability.